Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder

Clinical trial NCT07738952 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07738952
Sponsor: Kyushu University
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorder Attack

Start date: 2026-08-17
Primary completion: 2028-01-31
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.